Quantcast

Latest Organofluorides Stories

2014-02-11 08:31:56

Agency Proposes Select Phase I Studies as Part of Resubmission RALEIGH, N.C., Feb. 11, 2014 /PRNewswire/ -- Sprout Pharmaceuticals announced today that their Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the FDA on the path forward. Sprout will resubmit the New Drug Application (NDA) for flibanserin, a once-daily treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, by the third quarter. The FDA has requested...

2014-02-07 23:01:26

The Firm is evaluating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) February 07, 2014 With Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continuing to move forward in courts around the country, Bernstein Liebhard LLP notes the publication of yet another report detailing a rise in pediatric use of Risperdal and other...

2014-02-05 23:31:48

Recently, Fluorotherm – a leading company in the fluoropolymer products industry – has designed a new proprietary product: Fluoropolymer Heat-Conductive Tubing. It is presently available for purchase on their partner’s online shop, Fluorostore. Parsippany, NJ (PRWEB) February 05, 2014 The world of fluoropolymers is growing and changing at a rapid rate, and experts at the leading company Fluorotherm have taken the next big step in providing their newest product – Fluoropolymer...

2014-02-04 23:02:09

Wright & Schulte LLC is Investigating Risperdal Lawsuits on Behalf of Patients Who Used the Atypical Antipsychotic and Developed Gynecomastia, also Known as Male Breast Growth. Columbus, OH (PRWEB) February 04, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, announces they have launched a new Facebook page to provide the public with the most up-to-date information regarding the ongoing litigation of Risperdal gynecomastia claims. The...

2014-02-04 12:28:45

NEW YORK, Feb. 4, 2014 /PRNewswire/ -- As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to move forward in U.S. courts, a new analysis out of Germany indicates that more children in that country are being treated with antipsychotic drugs. The analysis, which appeared last month in Deutsches Arzteblatt International, looked at data collected by a German health insurer, and found that the use of such medications among children and adolescents grew significantly...

2014-02-03 08:27:37

SEATTLE AND BOULDER, CO, Feb. 3, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced the initiation of a Phase 1b trial of ONT-380 (ARRY-380) in combination with Xeloda® (capecitabine) and/or Herceptin® (trastuzumab) in patients with metastatic HER2+ breast cancer. ONT-380 is an orally active, reversible and selective small-molecule HER2 inhibitor invented by Array and being developed by Oncothyreon in collaboration with...

2014-02-03 08:20:59

Intergovernmental Panel on Climate Change report concludes that HFO-1234yf has a global warming potential that is less than 1 MORRIS TOWNSHIP, N.J., Feb. 3, 2014 /PRNewswire/ -- Honeywell (NYSE: HON) announced today that the Intergovernmental Panel on Climate Change (IPCC), a scientific body established by the United Nations, has confirmed that Honeywell's new low-global-warming automobile refrigerant, HFO-1234yf, has a global warming potential (GWP) that is less than 1, below that...

2014-02-02 23:01:23

The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin. New York, NY (PRWEB) February 02, 2014 Plaintiffs in Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to wait for a federal Panel’s decision on whether to consolidate cases over the cholesterol drug after inclement weather caused last week’s hearing on the matter to be postponed,...

2014-01-31 23:03:58

The Firm is investigating Risperdal lawsuits on behalf of individuals who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic medication. New York, New York (PRWEB) January 31, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege use of the antipsychotic medication caused gynecomastia (male breast growth) and other serious side effects continue to move forward in Courts around the country, Bernstein Liebhard LLP notes...

2014-01-29 23:31:56

National network of attorneys will resume availability to consumers inquiring about legal options to seek compensation over allegations that children suffered birth defects due to mothers’ use of SSRIs during pregnancies. San Diego, CA (PRWEB) January 29, 2014 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers who are seeking...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'